Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting

Benjamin Maasoumy; Kerstin Port; Antoaneta Angelova Markova; Beatriz Calle Serrano; Magdalena Rogalska-Taranta; Lisa Sollik; Carola Mix; Janina Kirschner; Michael P. Manns; Heiner Wedemeyer; Markus Cornberg

doi:10.1371/journal.pone.0055285

Loading metrics

Open Access

Peer-reviewed

Research Article

Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting

Benjamin Maasoumy,

Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
⨯
Kerstin Port,

Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
⨯
Antoaneta Angelova Markova,

Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
⨯
Beatriz Calle Serrano,

Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
⨯
Magdalena Rogalska-Taranta,

Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
⨯
Lisa Sollik,

Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
⨯
Carola Mix,

Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
⨯
Janina Kirschner,

Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
⨯
Michael P. Manns,

Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
⨯
Heiner Wedemeyer,

Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
⨯
Markus Cornberg

* E-mail: Cornberg.Markus@mh-hannover.de

Affiliation Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
⨯

Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting

Benjamin Maasoumy,
Kerstin Port,
Antoaneta Angelova Markova,
Beatriz Calle Serrano,
Magdalena Rogalska-Taranta,
Lisa Sollik,
Carola Mix,
Janina Kirschner,
Michael P. Manns,
Heiner Wedemeyer

Published: February 1, 2013
https://doi.org/10.1371/journal.pone.0055285

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Antiviral therapy
Is the Subject Area "Antiviral therapy" applicable to this article?

Thanks for your feedback.
Protease inhibitor therapy
Is the Subject Area "Protease inhibitor therapy" applicable to this article?

Thanks for your feedback.
Platelets
Is the Subject Area "Platelets" applicable to this article?

Thanks for your feedback.
Hepatitis C virus
Is the Subject Area "Hepatitis C virus" applicable to this article?

Thanks for your feedback.
Cirrhosis
Is the Subject Area "Cirrhosis" applicable to this article?

Thanks for your feedback.
Liver fibrosis
Is the Subject Area "Liver fibrosis" applicable to this article?

Thanks for your feedback.
Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Adverse events
Is the Subject Area "Adverse events" applicable to this article?

Thanks for your feedback.